Article No
155-96-978
BTLA Recombinant Protein
BTLA Recombinant Protein
Proteins & Peptides
Specifications
| MW | 42.7 kDa |
| Accession Number | Q32MV9 |
| Application | WB |
| Article No | 155-96-978 |
| Country Availability | SE, FI, DK, NO, IS, EE, LV, LT, FO, GL |
| Description | BTLA Recombinant Protein |
| Supplier | ProSci |
| Format | Lyophilized |
| Notes | B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM. |
| Alias Names | BTLA,CD272 |
| Previous Article No | 155-96-978-$100, 155-96-978-100 |
| Product Type | Proteins & Peptides |
| Protocol | This recombinant protein can be used for WB. For research use only. |
| Purity | >95% |
| Research area | Immunology |
| Sequence | Glu 30 - Gly 176 |
| Shipping Information | RT |
| Size | 0.1 mg |
| Storage | -20°C, -80°C |
| Substrate / Buffer | Tris with Glycine, Arginine and NaCl, pH7.5 |
| UniProt Number | Q32MV9 |
| Product Page Updated | 2024-01-03T13:34:25.701Z |
